Global Cancer Diagnostics Market Report 2015 - Technology, Imaging and by Applications Forecasts to 2020 for the $13 Billion Industry

News provided by

Jul 02, 2015, 10:35 ET

DUBLIN, June 25, 2015 /PRNewswire/ --

Research and Markets(http://www.researchandmarkets.com/research/nlfg34/cancer) has announced the addition of the "Cancer Diagnostics Market by Technology, Imaging and by Application - Forecast to 2020" report to their offering.

The global cancer diagnostics market is expected to reach $13.1 Billion in 2020 from an estimated $7.1 Billion in 2015, growing at a CAGR of 12.9%.

The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). The cancer diagnostics market in Asia is expected to grow at the highest rate from 2015 to 2020.

The cancer diagnostics market is highly competitive with a large number of big and small players operating in different market segments. Based on technology, this market is categorized into platform-based and instrument-based. The instrument-based cancer diagnostics segment is expected to account for a major share of this market, by product, in 2015.

Based on application, this market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma, and others. Breast cancer is expected to account for a major share of the cancer diagnostics applications market in 2015.

Technological advancements in various fields such as biomarkers, imaging, biopsy, and endoscopy; growing prevalence of cancer, rapid rise in aging population, increasing number of awareness initiatives by governments, and growing government funding. However, high capital investments and low benefit-cost ratio of biomarkers, and high cost of diagnostic imaging instruments pose restraints to the growth of this market. Improving healthcare infrastructure in emerging countries and growing demand of personalized medicines offer growth opportunities for this market.

Scope of the Report

Cancer Diagnostics Market, by Product

Platform-based
- Next-generation Sequencing
- Microarrays
- PCR
- Flow Cytometry
- In situ Hybridization
- Immunohistochemistry
- Others

Instrument-based

- Imaging Instruments
- MRI
- CT
- PET
- Ultrasound
- Mammography
- Biopsy

Cancer Diagnostics Market, by Application

- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Melanoma
- Others

Key Topics Covered:

Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Global Cancer Diagnostics Market, By Technology

7 Global Cancer Diagnostics Market, By Application

8 Market, By End User

9 Cancer Diagnostics Market, By Region

10 Competitive Landscape

11 Company Profiles

- Abbott Laboratories, Inc. (U.S.)
- Agilent Technologies, Inc. (U.S.)
- Becton, Dickinson and Company (U.S.)
- C.R. Bard, Inc. (U.S.)
- GE Healthcare (U.K.)
- Illumina, Inc. (Denmark)
- Philips Healthcare (U.K.)
- QIAGEN N.V. (Netherlands),
- Roche Diagnostics (Switzerland)
- Siemens Healthcare (Germany)
- Thermo Fisher Scientific, Inc. (U.S.)

For more information visit http://www.researchandmarkets.com/research/nlfg34/cancer